What question did this study set out to answer?

This study aims to evaluate the effectiveness of captopril at two different doses in preventing volume overload cardiomyopathy caused by chronic aortic regurgitation in rats.

March 1, 2004Canadian Journal of Physiology and Pharmacology

Angiotensin-converting enzyme inhibitor captopril prevents volume overload cardiomyopathy in experimental chronic aortic valve regurgitation

View Full Paper

Ask AI

Bookmark

Why the study?

Does captopril prevent left-ventricular volume overload cardiomyopathy in a rat model of severe chronic aortic regurgitation?

Population

Wistar rats with severe chronic aortic regurgitation (AR)

Comparison

Captopril 25 mg/kg or 75 mg/kg for 6 months vs Untreated Wistar rats with severe AR

Design

Preclinical

Follow-up

6 months

Authors

ÉPÉric PlanteSUNY Upstate Medical University MGMartin GaudreauUniversité Laval DLDominic LachanceLung Institute

Discussion

Member takes

Implication

Cautious interpretation required for humans; extends preclinical evidence for high-dose ACE inhibition in volume-overload models.

Key Points

This study aims to evaluate the effectiveness of captopril at two different doses in preventing volume overload cardiomyopathy caused by chronic aortic regurgitation in rats.
Evaluated low-dose (25 mg/kg) and high-dose (75 mg/kg) captopril over 6 months in Wistar rats with severe chronic aortic regurgitation.
Assessed left-ventricular function and hypertrophy through echocardiography and tissue analysis.
Measured angiotensin II receptor mRNA levels and fibronectin expression in cardiac tissues.
Low-dose treatment did not prevent left-ventricular hypertrophy and had modest effects on systolic dysfunction.
High-dose treatment preserved left-ventricular systolic function and dimensions, showing trends towards reduced hypertrophy.
High-dose treatment significantly decreased angiotensin II receptor mRNA and reversed fibronectin overexpression in the left ventricle.

Structured PICO

Does captopril prevent left-ventricular volume overload cardiomyopathy in a rat model of severe chronic aortic regurgitation?

Population

Wistar rats with severe chronic aortic regurgitation (AR)

Intervention

Captopril 25 mg/kg (low dose) or 75 mg/kg (high dose) for 6 months

Comparator

Untreated Wistar rats with severe AR

Outcome

Left-ventricular (LV) function and hypertrophysurrogate

High-dose captopril prevents volume overload cardiomyopathy and fibrosis in an experimental rat model of severe chronic aortic regurgitation.

Cite This Study

Plante et al. (2004) studied this question.

synapsesocial.com/papers/6a1cd80bc9d372840a89c751 https://doi.org/10.1139/y04-005

View Full Paper

Ask AI

Bookmark

Angiotensin-converting enzyme inhibitor captopril prevents volume overload cardiomyopathy in experimental chronic aortic valve regurgitation

Discussion

Member takes

Implication

Key Points

Structured PICO

Cite This Study

Angiotensin-converting enzyme inhibitor captopril prevents volume overload cardiomyopathy in experimental chronic aortic valve regurgitation

Discussion

Member takes

Implication

Key Points

Structured PICO

Cite This Study

Also Consider

Also Consider